{"organizations": [], "uuid": "649ae644621b43b01e682fba7394aa4d97c20b38", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-orexigen-therapeutics-says-plans-n/brief-orexigen-therapeutics-says-plans-near-term-sale-through-chapter-11-of-u-s-bankruptcy-code-idUSFWN1QT075", "country": "US", "domain_rank": 408, "title": "BRIEF-Orexigen Therapeutics says plans near-term sale through Chapter 11 of U.S. bankruptcy code", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-12T07:13:00.000+02:00", "replies_count": 0, "uuid": "649ae644621b43b01e682fba7394aa4d97c20b38"}, "author": "", "url": "https://www.reuters.com/article/brief-orexigen-therapeutics-says-plans-n/brief-orexigen-therapeutics-says-plans-near-term-sale-through-chapter-11-of-u-s-bankruptcy-code-idUSFWN1QT075", "ord_in_thread": 0, "title": "BRIEF-Orexigen Therapeutics says plans near-term sale through Chapter 11 of U.S. bankruptcy code", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "delaware", "sentiment": "none"}], "organizations": [{"name": "brief-orexigen therapeutics", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "orexigen therapeutics", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "orexigen therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 12, 2018 / 5:14 AM / Updated an hour ago BRIEF-Orexigen Therapeutics says plans near-term sale through Chapter 11 of U.S. bankruptcy code Reuters Staff 1 Min Read March 12 (Reuters) - Orexigen Therapeutics Inc: * OREXIGEN THERAPEUTICS, INC. PLANS FOR NEAR-TERM SALE USING STRUCTURED PROCESS THROUGH CHAPTER 11 OF U.S. BANKRUPTCY CODE * ‍ELECTED TO FILE A VOLUNTARY PETITION UNDER CHAPTER 11 OF BANKRUPTCY CODE IN U.S. BANKRUPTCY COURT FOR DISTRICT OF DELAWARE​ * OREXIGEN THERAPEUTICS- ‍INTENDS TO FILE A MOTION SEEKING AUTHORIZATION TO PURSUE AN AUCTION AND SALE PROCESS UNDER SECTION 363 OF U.S. BANKRUPTCY CODE​ * OREXIGEN THERAPEUTICS - ‍PROPOSED BIDDING PROCEDURES WOULD REQUIRE INTERESTED PARTIES TO SUBMIT BINDING OFFERS TO BUY SUBSTANTIALLY ALL OF CO’S ASSETS​ * PROPOSED ‍BIDS EXPECTED TO BE SUBMITTED BY MAY 21, 2018​ * OREXIGEN THERAPEUTICS-‍HAS SUPPORT OF CONTROLLING NUMBER OF SENIOR SECURED NOTEHOLDERS FOR PROCESS, WHO HAVE MADE A $35 MILLION FINANCING COMMITMENT​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-12T07:13:00.000+02:00", "crawled": "2018-03-12T08:14:02.030+02:00", "highlightTitle": ""}